Neutral Displacement Needles Market Report 2026

Neutral Displacement Needles Market Report 2026 Market Overview

• Neutral Displacement Needles Market Report 2026 market size has reached to $0.28 billion in 2025 • Expected to grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Increasing Focus On Preventing Catheter Related Bloodstream Infections Fueling The Growth Of The Market Due To Rising Catheter Associated Infection Risks • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neutral Displacement Needles Market?

Neutral displacement needles are medical access devices designed to maintain balanced fluid movement during connection and disconnection by minimizing unintended pressure changes within a closed system. They help support consistent fluid control while reducing the likelihood of reflux or fluid displacement, contributing to stable system performance and procedural reliability. The main product types of neutral displacement needles include standard neutral displacement devices, anti reflux neutral displacement devices, and closed system neutral displacement devices. Standard neutral displacement devices refer to needle-free vascular access connectors designed to maintain neutral fluid displacement during connection and disconnection, helping reduce catheter occlusion while supporting safe intravenous therapy. These devices utilize split septum valve and mechanical valve mechanisms and are manufactured using materials such as polycarbonate, polypropylene, silicone, and other medical grade polymers. They are distributed through direct sales, medical device distributors, group purchasing organizations, and healthcare suppliers and are utilized by end users such as hospitals, ambulatory surgical centers, specialty clinics, and home healthcare settings.

What Is The Neutral Displacement Needles Market Growth Forecast?

The neutral displacement needles market size is expected to see strong growth in the next few years. It will grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for advanced closed system drug delivery solutions, increasing adoption of infection control technologies in healthcare facilities, growing preference for efficient fluid management devices, expanding use of home infusion therapy services, increasing investment in next-generation medical access device development. Major trends in the forecast period include increasing adoption of closed system neutral displacement devices for improved infection prevention, growing demand for advanced fluid control solutions in intravenous therapy applications, rising preference for needle-free access devices to enhance healthcare worker safety, increasing focus on improved reflux prevention and fluid stability during medical procedures, growing development of biocompatible materials for safer and more reliable medical access devices.

What Are The Drivers Of The Neutral Displacement Needles Market?

The increasing focus on preventing catheter-related bloodstream infections (CRBSIs) is expected to propel the growth of the neutral displacement needles market going forward. A catheter-related bloodstream infection is a laboratory-confirmed bloodstream infection that develops in a patient with a central venous catheter in place, with no other identifiable source of infection. Catheter related bloodstream infections are rising due to increasing use of vascular catheters in critically ill and chronically ill patients, longer hospital stays, growing numbers of invasive procedures, and the increasing prevalence of antimicrobial resistant pathogens. Neutral displacement needles support catheter-related bloodstream infections by minimizing blood reflux and reducing microbial contamination at the catheter hub during intravenous access, thereby lowering the risk of catheter-related bloodstream infections in clinical settings. For instance, in February 2026, according to the UK Health Security Agency, a UK government health body, catheter-associated bloodstream infections accounted for 21.2% of all intensive care unit-associated bloodstream infections in adult units in financial year 2024 to 2025 (312 of 1,474 cases). Therefore, the increasing focus on preventing catheter-related bloodstream infections (CRBSIs) is driving the growth of the neutral displacement needles industry. The rising prevalence of healthcare-associated infections is expected to propel the growth of the neutral displacement needles market going forward. Healthcare-associated infections are infections that patients acquire while receiving medical treatment in hospitals, outpatient clinics, nursing homes, and other care settings, and they are not present at the time of admission. The prevalence of HAIs continues to rise due to the growing use of invasive medical devices such as central lines, urinary catheters, and ventilators, which create direct pathways for pathogens to enter the bloodstream. Neutral displacement needleless connectors reduce this risk by preventing blood reflux into the catheter lumen during disconnection, thereby lowering the likelihood of catheter-related bloodstream infections and supporting compliance with infection control protocols. For instance, in January 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, abdominal hysterectomy surgical site infections rose by 8% in 2024 compared to 2023, while approximately 1 in 31 hospitalized patients in the country contract at least one healthcare-associated infection during their care. Therefore, the rising prevalence of healthcare-associated infections is driving the growth of the neutral displacement needles industry. The increasing healthcare expenditure is expected to propel the growth of the neutral displacement needles market going forward. Healthcare expenditure refers to the total spending on medical goods, healthcare services, public health programs, and related activities aimed at maintaining or improving health. Healthcare expenditure is rising due to the increasing prevalence of chronic diseases, which drives greater demand for long-term treatments, frequent hospitalizations, diagnostic services, and ongoing medical care. The expansion of healthcare expenditure supports the adoption of neutral displacement needles by enabling healthcare facilities to invest in advanced vascular access devices that enhance infection prevention, improve patient safety, and strengthen compliance with clinical care standards. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, total non-government healthcare expenditure increased by 1.0% in real terms in 2023, reaching $74 billion (£58.2 billion). Therefore, the increasing healthcare expenditure is driving the growth of the neutral displacement needles industry.

Key Players In The Global Neutral Displacement Needles Market

Major companies operating in the neutral displacement needles market report are Medline Industries LP, Becton Dickinson and Company, ICU Medical Inc., Baxter International Inc., B. Braun Medical Inc., Fresenius Kabi India Private Limited, Teleflex Incorporated, Merit Medical Systems Inc., Vygon (UK) Ltd., Poly Medicure Limited, Amsino International Inc., CODAN US Corporation, Baihe Medical Technology Co. Ltd., Elcam Medical Group, GBUK Group Limited, Harsoria Healthcare Private Limited, NP Medical Inc., Shandong Ande Healthcare Apparatus Co. Ltd., Mediplus (India) Limited, Lars Medicare Private Limited, JCM MED Co. Ltd., MedicalRite, Asset Medical LLC

What Defines the Neutral Displacement Needles Market?

The neutral displacement needles market consists of sales of atraumatic displacement needles, blunt-tip displacement needles, specialty procedural needles, and related accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neutral Displacement Needles Market Report 2026?

The neutral displacement needles market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neutral displacement needles industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.